Development of targeted radiopharmaceuticals for the treatment of melanoma : a tale of lutetium-177 and terbium-161
Despite recent developments and the progress made in providing clinical solutions for the management of disease, melanoma continues to be a disease with a high mortality rate. In recent years, advances in clinical options for diagnosing and treating the disease have greatly improved patient management and improved pati...
E. Iweha
· 0 citations